YELESWARAM KRISHNASWAMY (Chief Development Officer) sold 0.1% of their position (360.00 shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $12.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/9/2026ACC: 0001193125-26-149725
Officer· Chief Development Officer
Since Feb 2026
-360.00
Net shares
Net seller
$12.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
360.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−360.00
Price / share
$34.90
Trade value
$12.56K
% of position
0.1%
4/8/2026
286.88K→286.52K
Total
Net shares
−360.00
Net value
-$12.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2026 | S · Sale | −360.00 | $34.90 | $12.56K | 0.1% | 286.88K | 286.52K |
| Total | −360.00 | -$12.56K | ||||||
Derivative Transactions0
No derivative transactions reported